Part B: 20 Questions and Answers Regarding Methadone Maintenance Treatment Research
View as PDF (1.19MB)
- Question 1: Is methadone maintenance treatment effective for opioid addiction?
- Question 2: Does methadone maintenance treatment reduce illicit opioid use?
- Question 3: Does methadone maintenance treatment reduce HIV risk behaviors and the incidence of HIV infection among opioid-dependent injection drug users?
- Question 4: Does methadone maintenance treatment reduce criminal activity?
- Question 5: Does methadone maintenance treatment improve the likelihood of obtaining and retaining employment?
- Question 6: What effect can methadone maintenance treatment have on the use of alcohol and other drugs?
- Question 7: What components of methadone maintenance treatment account for reductions in AIDS risk behaviors?
- Question 8: Do risk factors for HIV infection acquisition and transmission differ for women compared with men in methadone maintenance treatment?
- Question 9: Is methadone maintenance treatment effective for women?
- Question 10: Is methadone safe for pregnant women and their infants?
- Question 11: Is it necessary to reduce methadone dose or detoxify women from methadone during pregnancy to protect the fetus?
- Question 12: Is the long-term use of methadone medically safe, and is it well tolerated by patients?
- Question 13: Are there program characteristics associated with the success of methadone maintenance treatment?
- Question 14: Are there patient characteristics associated with the success of methadone maintenance treatment?
- Question 15: Are there cost benefits to methadone maintenance treatment?
- Question 16: What are the retention rates for methadone maintenance treatment?
- Question 17: Is mandated methadone maintenance treatment as effective as voluntary treatment?
- Question 18: What is the role of L-alpha-acetyl-methadol (LAAM)?
- Question 19: How do buprenorphine and methadone compare?
- Question 20: Can methadone and buprenorphine be abused?
.png)
Important Dates
NIDA International Forum
June 14–17, 2013
Online Registration Deadline:
May 6, 2013
InWomen’s 2013 Conference
Friday, June 14, 2013
San Diego, California, USA
FELLOWSHIPS
NIDA International Program Fellowships
Application Deadline:
April 1, 2013
NIDA Hubert H. Humphrey Drug Abuse Research Fellowships
Application Deadlines Vary
GRANTS
Fogarty HIV Research Training Program for Low- and Middle-Income
Country Institutions (D43)
Applications Due:
July 24, 2013
MEETINGS
American Psychiatric Association
May 18–22, 2013
San Francisco, California, USA
Society for Prevention Research
May 28–31, 2013
San Francisco, California, USA
College on Problems of Drug Dependence (CPDD)
June 15–20, 2013
San Diego, California, USA
